Overcome Matrix Shortage and Non-specific Binding Issues
Surrogate Cerebrospinal Fluid Method for ASO Quantitation
In this presentation, we identify a suitable surrogate matrix to overcome issues regarding the shortage of nonhuman primate matrices, and susceptibility to non-specific binding (inherent in the analysis of oligonucleotides), including the use of artificial cerebrospinal fluid.
Listen to the presentation!
You may also be interested in the following:
- eBook: Bioanalytical Developments for the Analysis of ASOs
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.